Partnered Content

Delve into the challenges facing the NHS, from rising medicine costs to supply shortages, and how generics and branded generics can provide solutions for a more sustainable healthcare system

Learn about the critical role the right CRO plays in successfully navigating the significant drug development opportunities in Japan.

Explore the challenges and opportunities of CAR T-cell therapy, a promising new treatment for addressing the unmet needs of autoimmune diseases.

In Partnership With

Discover Henlius’ groundbreaking achievements, and their mission to deliver affordable, innovative drugs worldwide through strategic partnerships.

Cell and gene therapy sponsors are increasingly faced with hard decisions focused around mitigating potential delays.

Sponsored by:

Blending Human Experts With AI Agents Cuts Costs, Increases Access, And Improves Customer Experience

Almost 50% of biopharma are con-sidering China for clinical studies because of vast patient pools, competitive approval pathways, and cost savings.

Oncology continues to lead the way as a therapeutic focus for the pharma industry.

Sponsored by:

CGTs are among the fastest-growing areas in therapeutics - explore the key strategies driving long-term commercial success across the entire product lifecycle.

Access key takeaways from a roundtable on the evolving landscape for rAAV-based gene therapies. Experts discussed approaches to clinical development, regulatory barriers, and the future outlook for AAV developers and lab services organizations.

Expert panelists discuss regulatory challenges, flexible approaches to assay selection, and applying scientific reasoning with guidelines to address immunogenicity and safety assessment challenges in oncology biologics and biosimilars.

Stay current with trends in infectious disease clinical trials, with fresh insights from a recent roundtable event. Discover how the landscape is evolving and what to expect in the future, with key takeaways from industry experts.

Sponsored by:

Computer systems validation (CSV) has long been a regulatory necessity but is considered time and resource-consuming to execute.

Sponsored by:

In recent years, global regulatory requirements have evolved in many areas of the MedTech product life cycle management.

Sponsored by:

Despite widespread recognition of the importance of diversity in clinical trials, most trials still fail to recruit diverse participants.

Fourier-transform infrared (FTIR) spectroscopy is one of the most common forms of infrared spectroscopy and one of the most popular analytical techniques for quality assurance (QA), quality control (QC), and materials identification in the pharmaceutical industry.

Discover how transforming field reps from “Wild Cards” to “Masters of the Message” in Pharma Omnichannel Marketing, enhances performance and mitigates risk.

In Partnership with EDQM

Discover what’s on the horizon for the pharma industry as truly transformative technologies revolutionize the way drugs are developed, delivered and manufactured.

Sponsored by:

With the pharmaceutical industry still adjusting to the potential impacts of Humira's loss of exclusivity, another milestone for biosimilars has been achieved in 2022.

In Partnership with EDQM

As we enter the third year of the COVID-19 pandemic, the pharma industry has begun to adapt and grow around its constraints and opportunities.

Learn more about how China’s biopharmas are going global by working with dependable and trustworthy companion diagnostics partners.

Cell and gene therapies (CGTs) are continuing to gain momentum in life sciences globally.

Catalytic hydrogenation is a proven green manufacturing process that can transform the synthesis of active pharmaceutical ingredients (API), driving down costs while reducing environmental impact.

The use of mRNA in modern therapeutics is growing in popularity and efficacy.

Gain exclusive insights into the biggest challenges biotechs face in oncology and uncover the latest opportunities to accelerate drug development.

Sponsored by:

Hematological oncology is a growing area of the global pharmaceutical pipeline, meaning more treatments in research and development are set to reach Phase I and II clinical studies.

With delays currently facing drug developers due to some contract manufacturing organizations (CMOs) experiencing backlogs, future expectations for these service providers are being redefined.

Sponsored by:

Discover how eClinical technology is transforming clinical trials, increasing efficiencies, streamlining processes, and speeding time to market. Explore what lies ahead for eClinical tech and what it means for stakeholders in terms of innovation, collaboration, and overcoming tough challenges in clinical research.

In this podcast, Andrew Warmington, Manufacturing Editor, Citeline, joins together with industry experts, Simone Secchi, R&D Process Chemist, Olon Group, and Matthieu CULIE, Head of MAB, Pierre Fabre, to discuss the challenges in the development and manufacturing of ADCs.

In this podcast, Janelle Hart, Managing Editor at Citeline, teams up with industry experts Mai Yee Mishir, Senior Director of Global Regulatory Affairs, and Sally-Ann McDowell, Senior Director of Clinical Development Strategy at Advanced Clinical, to discuss the vital role of HRQoL in clinical trials.

In this podcast, Janelle Hart, Managing Editor, Citeline, joins together with industry experts, Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector.